Actively Recruiting

Phase Not Applicable
Age: 18Years - 99Years
All Genders
NCT06650995

AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure

Led by Technical University of Munich · Updated on 2025-12-26

40

Participants Needed

1

Research Sites

73 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The investigators analyze the impact of exercise and ablation in patients with symptomatic short-persistent atrial fibrillation (Afib) and heart failure with preserved ejection fraction (HFpEF). It is hypothesized that the combination of ablation and exercise better improves peak oxygen consumption (VO2peak) through improvement of peripheral (exercise training) and central (ablation) adaptations. Exercise intervention will contain a 12-week combined, video-based, supervised, endurance, resistance and respiratory training.

CONDITIONS

Official Title

AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed heart failure with preserved ejection fraction
  • Symptomatic short-persistent atrial fibrillation diagnosed within 1 year of study inclusion
Not Eligible

You will not qualify if you...

  • Paroxysmal, long-persistent, or permanent atrial fibrillation
  • Clinically unstable coronary artery disease or acute coronary syndrome
  • Physical or mental inability to perform exercise testing
  • Prior ablation therapy
  • Precapillary pulmonary hypertension at rest
  • Intracardiac shunts
  • Left ventricular ejection fraction less than 50%
  • High-degree valve insufficiency or stenosis greater than grade 1 at rest

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Medicine, Division of Prevention and Sports Medicine TU Munich

Munich, Germany, 80809

Actively Recruiting

Loading map...

Research Team

M

Martin Halle, Professor

CONTACT

M

Manuel Rattka, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here